MedPath

AHS Cancer Control Alberta

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website

Metabolism of Lipids in Advanced Cancer

Terminated
Conditions
Lung Neoplasms
Cachexia
Interventions
Other: Blood draws
Biological: Oral administration of stable isotope (deuterium)
Procedure: Metabolic rate testing
First Posted Date
2009-08-19
Last Posted Date
2016-02-26
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
12
Registration Number
NCT00962234
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone

Terminated
Conditions
Bone Scan
Interventions
Other: 18F-Sodium Fluoride (Na18F)
First Posted Date
2009-06-17
Last Posted Date
2024-06-12
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
645
Registration Number
NCT00922519
Locations
🇨🇦

Princess Margaret Hospital, Toronto, Ontario, Canada

🇨🇦

St. Joseph's Healthcare, Hamilton, Ontario, Canada

🇨🇦

Sunnybrook Health Services Centre, Toronto, Ontario, Canada

and more 4 locations

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Phase 2
Completed
Conditions
Small Cell Carcinoma
Lung Neoplasm
First Posted Date
2009-05-22
Last Posted Date
2016-02-22
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
2
Registration Number
NCT00907569
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Phase 1
Completed
Conditions
Non-small Cell Lung Cancer
First Posted Date
2009-04-28
Last Posted Date
2016-03-16
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
13
Registration Number
NCT00888823
Locations
🇨🇦

Tom Baker Cancer Center, Calgary, Alberta, Canada

🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors

Phase 2
Completed
Conditions
Colonic Neoplasms
Interventions
Other: Usual Care
Behavioral: Exercise Training
First Posted Date
2008-12-23
Last Posted Date
2016-03-11
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
52
Registration Number
NCT00813540
Locations
🇨🇦

Cross Cancer Institue, Edmonton, Alberta, Canada

Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components

Conditions
Glioma
First Posted Date
2008-12-23
Last Posted Date
2014-10-03
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
20
Registration Number
NCT00813787
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

Phase 2
Terminated
Conditions
Breast Neoplasm
Interventions
Drug: FluGlucoScan Injection (18F-FDB) PET scan
First Posted Date
2008-10-13
Last Posted Date
2019-08-22
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
23
Registration Number
NCT00771381
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

Conditions
Cell Hypoxia
Lung Neoplasm
Interventions
Other: 18F-FAZA
Other: 18F-Fluorodeoxyglucose (18F-FDG)
First Posted Date
2008-10-03
Last Posted Date
2014-10-03
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
30
Registration Number
NCT00765986
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Procedure: 3T MR Spectroscopy
First Posted Date
2008-09-22
Last Posted Date
2016-07-18
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
10
Registration Number
NCT00756392
Locations
🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Withdrawn
Conditions
Hypoxic Tumours
Interventions
Other: 18F-FAZA
First Posted Date
2008-09-22
Last Posted Date
2017-11-14
Lead Sponsor
AHS Cancer Control Alberta
Registration Number
NCT00756691
© Copyright 2025. All Rights Reserved by MedPath